Navigation Links
Axial Biotech Wins 2010 Best New Spinal Technology Award
Date:10/5/2010

SALT LAKE CITY, Oct. 5 /PRNewswire/ -- Axial Biotech, Inc., a company revolutionizing spine care through the development of molecular diagnostic technologies, was selected as a winner at the 2010 Spine Technology Awards. Sponsored by Orthopedics This Week, the largest weekly publication in the spine industry, the 2010 Spine Technology Awards received submissions from hundreds of outstanding technologies. Robin Young, the Publisher of Orthopedics This Week, presented the award to Axial Biotech during an awards ceremony held last night, in advance of the North American Spine Society Meeting in Orlando, Florida

Axial Biotech's award winning product, ScoliScore™AIS Prognostic Test, won in the diagnostics category. The ScoliScore test is the first-ever genetic test for patients diagnosed with Adolescent Idiopathic Scoliosis (AIS). This new molecular diagnostic tool marks a major advancement in which medical treatments can be personalized to patients diagnosed with this deforming disease.

ScoliScore™ was developed by utilizing a genome wide association study that identified a panel of genetic markers associated with severe curve progression. The scoliosis research used in the development of this test included collecting DNA samples from over 10,000 patients from over 100 IRB approved clinical sites throughout the world. The test was then further validated in three separate clinical trials.

The Spine Technology Awards were judged according to their likelihood to advance the care of spine care and treatment using innovative and new technologies. The 30-surgeon panel of judges was selected for their clinical experience and independence -- none were affiliated with the winning technologies. Since treating spinal disorders is one of the most complex medical problems, new technologies have historically played a significant role in advancing the cause of patient care.

Speaking at the awards gala, Orthopedics This Week Publisher Robin Young said, "The spine industry relies on the inspiration and perspiration of researchers, engineers and surgeon-inventors to improve outcomes and control costs. Most of these innovators are little known, so we are proud to provide these awards and a venue to recognize their great talents and contributions."

John Climaco, Axial Biotech's President and CEO accepted the award on behalf of the company. "We are honored to have won the 2010 Spine Technology Award for diagnostics," said Mr. Climaco.  "I am pleased that the distinguished panel of surgeon experts, recognized the unique value of ScoliScore™. Winning the Spinal Technology Award represents tremendous validation for all of the hard work of Axial's employees and all of the surgeons and their staff who participated in the development of this beneficial new technology."

For more information on the ScoliScore™ test, please contact Axial Biotech's Customer Service at 877-AXIAL98 (877-294-2598) or visit the company's website at www.axialbiotech.com

About Axial Biotech  

Axial Biotech, Inc. is the leading developer of molecular diagnostics for common spinal diseases and disorders. Axial markets the SCOLISCORE™ AIS Prognostic Test, the first and only test that utilizes the genetic blueprint of progressive scoliosis to enable physicians to identify which patients are likely to progress to a severe curvature. Axial is accredited by the College of American Pathologists (CAP) and is certified to comply with the Clinical Laboratory Improvement Amendments (CLIA). Axial is a privately held, venture-backed molecular diagnostics company founded in 2002 by a group of internationally recognized spine surgeons and geneticists. The company is based in Salt Lake City, Utah.


'/>"/>
SOURCE Axial Biotech, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reimbursement Difficulties With TranS1s AxiaLIF and NuVasives XLIF Have Sceptics Talking
2. Researchers at Axial Biotech Develop a DNA Test for Scoliosis
3. First of many Neuro-Biotechs licensed products, "SymPath(R) blood test"
4. Regeneron Announces Panel Discussion at Citis 5th Annual Biotech Day
5. Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum
6. FierceBiotech Names VentiRx Pharmaceuticals as One of the Fierce 15 Biotech Companies of 2010
7. FierceBiotech Names Obesity Company Gelesis to Fierce 15 List of Top Emerging Biotech Companies
8. Amira Pharmaceuticals Named One of Most Promising Biotech Companies by FierceBiotechs Annual Fierce 15
9. FierceBiotech Designates Alder Biopharmaceuticals One of Top Private Biotechs, Member of the 2010 Fierce 15
10. Champions Biotechnology Announces Agreement With Cephalon for the Evaluation of a Novel Oncology Compound Using Predictive Biomerk Tumorgraft™ Platform
11. Pevion Biotech Appoints New CEO and Secures CHF 10 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ANKENY, Iowa , 11 de fevereiro de ... a inauguração de sua fábrica de soroalbumina bovina ... Nova Zelândia. A fábrica fica na Ilha Norte ... Loop "), desenvolvido e estabelecido na fábrica da ... Iowa . O projeto e instalação dos ...
(Date:2/11/2016)... 2016 Breast Cancer Therapeutics in Asia-Pacific ... Asia-Pacific (APAC) breast cancer market will experience considerable ... 2021, at a Compound Annual Growth Rate (CAGR) of 8.5%. ... 2021 - states that the Asia-Pacific ... $1.9 billion in 2014 to $3.4 billion by 2021, at ...
(Date:2/11/2016)... , February 11, 2016 Jeffrey ... Worldwide Clinical Trials, will present at this year,s Summit for ... Hyatt Regency in Miami, FL. Zucker ... to optimize study execution, supporting SCOPE,s "Improving Site Study Activation ... place on Thursday, Feb. 25 at 11:05 a.m. ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... 11, 2016 , ... Student-doctors from Western University of Health ... Tuesday, February 9, taking one of the final steps in their medical school ... across the country. Of the 103 student-doctors who comprise the College of Osteopathic ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... Image ... business to a new market, and it’s the buildings of Nashville that will benefit. ... when I needed to relocate to Nashville, there was no question that I would ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... and women’s health, is pleased to announce the promotions of Allison Kelly to ... team, Steve Catone to executive vice president of North American capital sales, and ...
(Date:2/11/2016)... Australia (PRWEB) , ... February 11, 2016 , ... ... potential ?" motivational speaker, trainer and author Ray Clarke poses a question as ... personal fulfillment . In his book, "Being in the Being" (published by Partridge ...
(Date:2/11/2016)... Island, NY (PRWEB) , ... February 11, 2016 ... ... has enhanced and updated its hallmark resource, Infusion Therapy Standards of Practice, to ... leader in vein illumination with an estimated 85% share of the market, facilitates ...
Breaking Medicine News(10 mins):